Alan Leviton1, Elizabeth N Allred1, Raina N Fichorova2, Deborah K VanderVeen3, T Michael O'Shea4, Karl Kuban5, Olaf Dammann6,7. 1. Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. 2. Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 3. Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. 4. Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina. 5. Division of Neurology, Department of Pediatrics, Boston Medical Center, Boston University, Boston, Massachusetts. 6. Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts. 7. Perinatal Neuropidemiology Unit, Hannover Medical School, Hannover, Germany.
Abstract
OBJECTIVE: To evaluate to what extent indicators of placenta insufficiency are associated with low concentrations of insulin-like growth factor 1 (IGF-1) and IGF-1-binding protein-1 (IGFBP-1) in neonatal blood, and to what extent the concentrations of these growth factors are associated with concentrations of proteins with inflammatory, neurotrophic, or angiogenic properties. STUDY DESIGN: Using multiplex immunoassays, we measured the concentrations of IGF-1 and IGFBP-1, as well as 25 other proteins in blood spots collected weekly from ≥ 880 infants born before the 28th week of gestation, and sought correlates of concentrations in the top and bottom quartiles for gestational age and day the specimen was collected. RESULTS: Medically indicated delivery and severe fetal growth restriction (sFGR) were associated with low concentrations of IGF-1 on the first postnatal day and with high concentrations of IGFBP-1 on almost all days. Elevated concentrations of IGF-1 and IGFBP-1 were accompanied by elevated concentrations of many other proteins with inflammatory, neurotrophic, or angiogenic properties. CONCLUSION: Disorders associated with impaired placenta implantation and sFGR appear to account for a relative paucity of IGF-1 on the first postnatal day. Elevated concentrations of IGF-1 and especially IGFBP-1 were associated with same-day elevated concentrations of inflammatory, neurotrophic, and angiogenic proteins. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
OBJECTIVE: To evaluate to what extent indicators of placenta insufficiency are associated with low concentrations of insulin-like growth factor 1 (IGF-1) and IGF-1-binding protein-1 (IGFBP-1) in neonatal blood, and to what extent the concentrations of these growth factors are associated with concentrations of proteins with inflammatory, neurotrophic, or angiogenic properties. STUDY DESIGN: Using multiplex immunoassays, we measured the concentrations of IGF-1 and IGFBP-1, as well as 25 other proteins in blood spots collected weekly from ≥ 880 infants born before the 28th week of gestation, and sought correlates of concentrations in the top and bottom quartiles for gestational age and day the specimen was collected. RESULTS: Medically indicated delivery and severe fetal growth restriction (sFGR) were associated with low concentrations of IGF-1 on the first postnatal day and with high concentrations of IGFBP-1 on almost all days. Elevated concentrations of IGF-1 and IGFBP-1 were accompanied by elevated concentrations of many other proteins with inflammatory, neurotrophic, or angiogenic properties. CONCLUSION: Disorders associated with impaired placenta implantation and sFGR appear to account for a relative paucity of IGF-1 on the first postnatal day. Elevated concentrations of IGF-1 and especially IGFBP-1 were associated with same-day elevated concentrations of inflammatory, neurotrophic, and angiogenic proteins. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Authors: Alan Leviton; Elizabeth N Allred; Raina N Fichorova; T Michael O'Shea; Lynn A Fordham; Karl K C Kuban; Olaf Dammann Journal: Eur J Paediatr Neurol Date: 2018-01-31 Impact factor: 3.140
Authors: Ann Hellström; David Ley; Ingrid Hansen-Pupp; Boubou Hallberg; Luca A Ramenghi; Chatarina Löfqvist; Lois E H Smith; Anna-Lena Hård Journal: Am J Perinatol Date: 2016-09-07 Impact factor: 1.862
Authors: Alan Leviton; T Michael O'Shea; Francis J Bednarek; Elizabeth N Allred; Raina N Fichorova; Olaf Dammann Journal: Acta Paediatr Date: 2011-12-07 Impact factor: 2.299
Authors: Gary W Hunninghake; Kevin C Doerschug; Amanda B Nymon; Gregory A Schmidt; David K Meyerholz; Alix Ashare Journal: Am J Respir Crit Care Med Date: 2010-04-22 Impact factor: 21.405
Authors: Jennifer W Lee; Deborah VanderVeen; Elizabeth N Allred; Alan Leviton; Olaf Dammann Journal: Acta Paediatr Date: 2014-10-23 Impact factor: 2.299
Authors: Ignacio Herraiz; Elisa Simón; Paula Isabel Gómez-Arriaga; José Manuel Martínez-Moratalla; Antonio García-Burguillo; Elena Ana López Jiménez; Alberto Galindo Journal: Int J Mol Sci Date: 2015-08-13 Impact factor: 5.923
Authors: Ann Hellström; David Ley; Ingrid Hansen-Pupp; Boubou Hallberg; Chatarina Löfqvist; Linda van Marter; Mirjam van Weissenbruch; Luca A Ramenghi; Kathryn Beardsall; David Dunger; Anna-Lena Hård; Lois E H Smith Journal: Acta Paediatr Date: 2016-03-08 Impact factor: 2.299
Authors: Mandy B Belfort; Sara E Ramel; Camilia R Martin; Raina Fichorova; Karl C K Kuban; Timothy Heeren; Rebecca C Fry; T Michael O'Shea Journal: J Pediatr Date: 2021-09-08 Impact factor: 4.406
Authors: Jacqueline T Bangma; Hadley Hartwell; Hudson P Santos; T Michael O'Shea; Rebecca C Fry Journal: Pediatr Res Date: 2020-11-12 Impact factor: 3.756